• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks Open Higher; US Trade Deficit Widens In April

    6/7/23 9:47:18 AM ET
    $BASE
    $CJET
    $CRT
    $MOND
    Computer Software: Prepackaged Software
    Technology
    Auto Manufacturing
    Industrials
    Get the next $BASE alert in real time by email

    U.S. stocks traded mostly higher this morning, with Nasdaq Composite gaining over 75 points on Wednesday.

    Following the market opening Wednesday, the Dow traded up 0.05% to 33,590.92 while the NASDAQ rose 0.55% to 13,349.38. The S&P 500, also rose, gaining, 0.18% to 4,291.74.

    Check This Out: Nvidia, Coinbase And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    • Energy shares jumped by 1.1% on Wednesday. Meanwhile, top gainers in the sector included Verde Clean Fuels, Inc. (NASDAQ:VGAS), up 6%, and Cross Timbers Royalty Trust (NYSE:CRT), up 4%.
    • In trading on Wednesday, consumer staples shares fell by 0.4%.

     

    Top Headline

    The trade deficit in the U.S. increased to a six-month high level of $74.6 billion in April, versus a $60.6 billion gap in the prior month. Exports from the U.S. fell by $9.2 billion from a month ago to $249 billion in April, while imports rose by $4.8 billion to $323.6 billion.

     

    Equities Trading UP

    • Yext, Inc. (NASDAQ:YEXT) shares shot up 34% to $12.90 after the company reported better-than-expected first-quarter results and issued strong FY24 forecast.
    • Shares of Chijet Motor Company, Inc. (NASDAQ:CJET) got a boost, shooting 23% to $5.15 after dropping around 29% on Tuesday.
    • Stitch Fix, Inc. (NASDAQ:SFIX) shares were also up, gaining 28% to $4.70 as the company reported better-than-expected results for its third quarter.

     

    Equities Trading DOWN

    • Mondee Holdings, Inc. (NASDAQ:MOND) shares dropped 26% to $9.39 after the company reported pricing of secondary offering of common stock by selling stockholders.
    • Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) were down 15% to $11.70. NewAmsterdam Pharma priced its 13,857 million share secondary offering of ordinary shares at $11.50 per share.
    • Couchbase, Inc. (NASDAQ:BASE) was down, falling 16% to $18.68 after the company posted first-quarter earnings and issued weak second-quarter sales forecast.

    Also Check This Out: Bitcoin, Ethereum Gain Following Economic Data; Stacks Emerges As Top Gainer

     

    Commodities

    In commodity news, oil traded up 1% to $72.46 while gold traded down 0.2% at $1,977.50.

    Silver traded up 0.1% to $23.695 on Wednesday while copper rose 0.5% to $3.7870.

     

    Euro zone

    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index rose 0.9% The German DAX gained 0.1% French CAC 40 rose 0.1% and Italy’s FTSE MIB Index fell 0.3%.

    Retail sales in Italy rose 0.2% from the prior month in April. France reported a current account gap of EUR 0.1 billion in April 2023, versus a revised EUR 0.3 billion surplus in the prior month. French trade deficit increased to EUR 9.7 billion in April versus a revised EUR 8.4 billion gap in the prior month. Industrial production in Germany rose 0.3% month-over-month in April. The Halifax house price index in the UK declined 1% year-over-year in May.

     

    Asia Pacific Markets

    Asian markets closed mostly higher on Wednesday, with Japan’s Nikkei 225 dropping 1.82%, Hong Kong’s Hang Seng Index gaining 0.80% and China’s Shanghai Composite Index gaining 0.08%. India’s S&P BSE Sensex rose 0.56%.

    Austria recorded a trade surplus of EUR 0.44 billion in March versus a year-ago deficit of EUR 1.61 billion, while the country’s economy expanded 0.2% qoq in the first quarter. Foreign exchange reserves in Hong Kong fell to a seven-month low of $421 billion in May, while Chinese foreign exchange reserves declined to $3.177 trillion in May. Chinese trade surplus narrowed to $65.81 billion in May from $78.40 billion in the year-ago period.

    The index of leading economic indicators in Japan rose to 97.6 in April from a final reading of 96.9 in the prior month, while index of coincident economic indicators climbed to 99.4 in April versus a 99.2 in the previous month.

     

    Economics

    • Mortgage applications in the US dropped 1.4% in the week ended June 2, 2023.
    • The trade deficit in the U.S. increased to a six-month high level of $74.6 billion in April, versus a $60.6 billion gap in the prior month. Exports from the U.S. fell by $9.2 billion from a month ago to $249 billion in April, while imports rose by $4.8 billion to $323.6 billion.

    Now Read This: Check Out 3 Financial Stocks With Over 7% Dividend Yields From Wall Street's Most Accurate Analysts

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,147,350 cases with around 1,166,160 deaths. India confirmed a total of at least 44,992,090 cases and 531,880 deaths, while France reported over 40,102,440 COVID-19 cases with 167,420 deaths. In total, there were at least 690,000,260 cases of COVID-19 worldwide with more than 6,888,820 deaths.

    Get the next $BASE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BASE
    $CJET
    $CRT
    $MOND

    CompanyDatePrice TargetRatingAnalyst
    NewAmsterdam Pharma Company N.V.
    $NAMS
    10/20/2025$52.00Buy
    H.C. Wainwright
    NewAmsterdam Pharma Company N.V.
    $NAMS
    8/25/2025$45.00Overweight
    Wells Fargo
    NewAmsterdam Pharma Company N.V.
    $NAMS
    7/17/2025$27.00Neutral
    Goldman
    Stitch Fix Inc.
    $SFIX
    7/14/2025Mkt Perform → Outperform
    William Blair
    Couchbase Inc.
    $BASE
    6/23/2025$25.00Outperform → Neutral
    Robert W. Baird
    NewAmsterdam Pharma Company N.V.
    $NAMS
    6/17/2025$42.00Buy
    Citigroup
    NewAmsterdam Pharma Company N.V.
    $NAMS
    6/10/2025$44.00Buy
    Stifel
    NewAmsterdam Pharma Company N.V.
    $NAMS
    6/4/2025$42.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $BASE
    $CJET
    $CRT
    $MOND
    SEC Filings

    View All

    SEC Form SC TO-I filed by Yext Inc.

    SC TO-I - Yext, Inc. (0001614178) (Subject)

    2/10/26 8:13:50 AM ET
    $YEXT
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Verde Clean Fuels Inc.

    SCHEDULE 13G/A - Verde Clean Fuels, Inc. (0001841425) (Subject)

    2/9/26 4:09:21 PM ET
    $VGAS
    Major Chemicals
    Industrials

    Verde Clean Fuels Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Verde Clean Fuels, Inc. (0001841425) (Filer)

    2/6/26 4:28:54 PM ET
    $VGAS
    Major Chemicals
    Industrials

    $BASE
    $CJET
    $CRT
    $MOND
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lake Katrina converted options into 8,835 shares and sold $44,232 worth of shares (8,835 units at $5.01) (SEC Form 4)

    4 - Stitch Fix, Inc. (0001576942) (Issuer)

    2/4/26 4:20:09 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Accounting Officer Kooij Louise Frederika exercised 72,428 units of Ordinary Shares at a strike of $10.90 and sold $2,335,860 worth of Ordinary Shares (72,428 units at $32.25) (SEC Form 4)

    4 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)

    1/29/26 4:40:24 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer O'Connor Casey exercised 19,347 shares at a strike of $3.80 and sold $109,891 worth of shares (19,347 units at $5.68) (SEC Form 4)

    4 - Stitch Fix, Inc. (0001576942) (Issuer)

    1/29/26 4:13:58 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BASE
    $CJET
    $CRT
    $MOND
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yext, Inc. Announces Commencement of Modified Dutch Auction Tender Offer to Purchase Up to $180 Million of its Common Stock

    Yext, Inc. (NYSE:YEXT), the leading brand visibility platform, today announced that it commenced a "modified Dutch Auction" tender offer to purchase up to $180 million in value of shares of its issued and outstanding common stock, or such lesser number of shares of its common stock as are properly tendered and not properly withdrawn, at a price not less than $5.75 per share nor greater than $6.50 per share, to the seller in cash, less any applicable withholding taxes and without interest. The tender offer is made in accordance with the terms and subject to the conditions described in the offer to purchase and the related letter of transmittal, as each may be amended or supplemented from tim

    2/10/26 8:00:00 AM ET
    $YEXT
    EDP Services
    Technology

    Verde Clean Fuels, Inc. Announces Suspension of Development of Permian Basin Project

    Verde Clean Fuels, Inc. (NASDAQ:VGAS) ("Verde" or the "Company") announced today the suspension of development of its Permian Basin project primarily as a result of changing market conditions driven by increasing demand for natural gas in the Permian Basin. In February 2024, the Company and Cottonmouth Ventures, LLC ("Cottonmouth"), a wholly-owned subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) ("Diamondback") entered into a joint development agreement ("JDA") to develop a natural gas-to-gasoline plant in the Permian Basin utilizing Verde's STG+® technology and associated natural gas from Diamondback's operations (the "Permian Basin Project"). Following announcement of the JDA, the C

    2/6/26 4:15:00 PM ET
    $FANG
    $VGAS
    Oil & Gas Production
    Energy
    Major Chemicals
    Industrials

    Yext CEO Withdraws Non-Binding Acquisition Proposal; Company Intends to Repurchase $150 Million of Common Stock Through Self-Tender Offer

    Yext, Inc. (NYSE:YEXT), the leading brand visibility platform, today announced that Michael Walrath, its Chief Executive Officer and Chairman of the Board of Directors, has withdrawn his previously announced proposal to acquire all outstanding shares of the Company not already owned by him at a price of $9.00 per share in cash. Mr. Walrath informed the Board of Directors that he would not be able to obtain the necessary financing at the price set forth in his proposal. Mr. Walrath further assured the Board of Directors that he remains committed to leading Yext as its Chief Executive Officer, and the Board of Directors remains confident in Mr. Walrath's ability to do so. As previously anno

    2/2/26 8:00:00 AM ET
    $YEXT
    EDP Services
    Technology

    $BASE
    $CJET
    $CRT
    $MOND
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Topper James N bought $15,639 worth of Ordinary Shares (660 units at $23.70) (SEC Form 4)

    4 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)

    9/17/25 5:22:34 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Topper James N bought $31,487 worth of Ordinary Shares (1,260 units at $24.99) (SEC Form 4)

    4 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)

    9/10/25 5:19:10 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Topper James N bought $11,294 worth of Ordinary Shares (471 units at $23.98) (SEC Form 4)

    4 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)

    8/13/25 4:49:54 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BASE
    $CJET
    $CRT
    $MOND
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright resumed coverage on NewAmsterdam Pharma with a new price target

    H.C. Wainwright resumed coverage of NewAmsterdam Pharma with a rating of Buy and set a new price target of $52.00

    10/20/25 8:45:44 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wells Fargo initiated coverage on NewAmsterdam Pharma with a new price target

    Wells Fargo initiated coverage of NewAmsterdam Pharma with a rating of Overweight and set a new price target of $45.00

    8/25/25 8:22:07 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman initiated coverage on NewAmsterdam Pharma with a new price target

    Goldman initiated coverage of NewAmsterdam Pharma with a rating of Neutral and set a new price target of $27.00

    7/17/25 8:08:01 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BASE
    $CJET
    $CRT
    $MOND
    Leadership Updates

    Live Leadership Updates

    View All

    Couchbase Announces Appointment of BJ Schaknowski as CEO and Amir Jafari as CFO

    SAN JOSE, Calif., Sept. 29. 2025 /PRNewswire/ -- Couchbase, Inc. ("Couchbase"), the developer data platform for critical applications in our AI world, today announced that it has appointed BJ Schaknowski as the company's new Chief Executive Officer and Amir Jafari as Chief Financial Officer, effective immediately. Mr. Schaknowski succeeds Matt Cain who is stepping down as Chair, President, and Chief Executive Officer. Mr. Schaknowski is a seasoned software industry executive with more than 20 years of experience in various leadership roles. Most recently he served as the Chief

    9/29/25 12:00:00 PM ET
    $BASE
    Computer Software: Prepackaged Software
    Technology

    Chijet Motor Company Taps Blockchain Veteran Jason Miller as COO to Spearhead Crypto Treasury Overhaul and Capitalize on Surging Digital Asset Growth

    New York, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Chijet Motor Company, Inc. (NASDAQ:CJET) ("Chijet" or the "Company") today announced the appointment of Jason Miller as Chief Operating Officer (COO), effective immediately, to spearhead the Company's transition into the digital currency era. This move positions the Company to integrate major cryptocurrencies such as Bitcoin (BTC), Ethereum (ETH), and Solana (SOL) into its balance sheet. Miller's expertise will drive enhanced financial resilience, optimized asset allocation, and participation in the decentralized finance (DeFi) ecosystem, aligning with the accelerating institutional adoption of digital assets. Miller possesses more than two dec

    9/19/25 7:15:00 AM ET
    $CJET
    Auto Manufacturing
    Industrials

    NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

    NAARDEN, the Netherlands and MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease ("CVD") with elevated low-density lipoprotein cholesterol ("LDL-C"), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Adele Gulfo as an independent director to its Board of Directors. Ms. Gulfo is an established pharmaceutical leader with over three decades of experience in the healthcare industry, distinguished by her expertise in global strategy, operations leadership, and the

    4/17/25 4:01:00 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BASE
    $CJET
    $CRT
    $MOND
    Financials

    Live finance-specific insights

    View All

    Yext Announces Third Quarter Fiscal 2026 Results

    Revenue of $112.0 million EPS, basic, of $0.05 or non-GAAP EPS of $0.14 Adjusted EBITDA of $27.2 million, resulting in an Adjusted EBITDA margin of 24% ARR of $444.4 million Yext, Inc. (NYSE:YEXT), the leading brand visibility platform, today announced its results for the three months ended October 31, 2025, or Yext's third quarter of fiscal year 2026. The Yext Board of Directors and its Special Committee continues to work with its advisors to carefully review and consider Michael Walrath's non-binding proposal to acquire the company, as well as any other strategic alternatives that may be available, consistent with its fiduciary duties to stockholders. In light of the pending pro

    12/8/25 4:05:00 PM ET
    $YEXT
    EDP Services
    Technology

    Stitch Fix Announces Date for First Quarter 2026 Financial Results and Conference Call

    Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its first quarter fiscal year 2026 ended November 1, 2025 after market close on Thursday, December 4, 2025. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone particip

    11/13/25 4:05:00 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    Yext Announces Second Quarter Fiscal 2026 Results

    Revenue of $113.1 million, up 16% year-over-year, driven by the integration of Hearsay Systems EPS, basic, of $0.22 or non-GAAP EPS of $0.13 Adjusted EBITDA of $26.4 million, resulting in an Adjusted EBITDA margin of 23% ARR of $444.4 million Yext, Inc. (NYSE:YEXT), the leading brand visibility platform, today announced its results for the three months ended July 31, 2025, or Yext's second quarter of fiscal year 2026. Yext exceeded its prior quarterly guidance for both revenue and Adjusted EBITDA, and was within the high end of its range for non-GAAP EPS. On August 18, 2025, Yext announced that Michael Walrath, its Chief Executive Officer and Chairman of the Board of Director

    9/8/25 4:05:00 PM ET
    $YEXT
    EDP Services
    Technology

    $BASE
    $CJET
    $CRT
    $MOND
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 5:35:24 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 4:00:47 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 10:28:58 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care